ALSA Ventures launches novel Gene Therapy portfolio company Axovia Therapeutics to treat Ciliopathies
19 sept. 2023 07h03 HE
|
Axovia Therapeutics LTD
Developing the first gene therapy to treat diseases caused by cilia dysfunctionAXV101 targets retinal dystrophy for Bardet-Biedl Syndrome (BBS) patientsFDA Orphan Drug Designation and Rare Pediatric...